These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 15993950)
61. Dendritic cell-tumor fusion vaccines for renal cell carcinoma. Avigan D Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6347S-52S. PubMed ID: 15448029 [TBL] [Abstract][Full Text] [Related]
62. Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens. Lambert LA; Gibson GR; Maloney M; Barth RJ J Immunother; 2001; 24(3):232-6. PubMed ID: 11394500 [TBL] [Abstract][Full Text] [Related]
63. [IL-15 enhance the therapeutic effects of whole cell vaccine in mouse CT26 colon carcinoma model]. Zhao YW; Li ZM; Zhao CJ; Zhang L; Jin L; Wang XF; Yang HS Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):567-70, 594. PubMed ID: 20848770 [TBL] [Abstract][Full Text] [Related]
64. Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells. Kuriyama H; Shimizu K; Lee W; Kjaergaard J; Parkhurst MR; Cohen PA; Shu S Dev Biol (Basel); 2004; 116():169-78; discussion 179-86. PubMed ID: 15603192 [TBL] [Abstract][Full Text] [Related]
65. [Inducing specific antitumor effects on osteosarcoma by fused vaccine of rat dendritic cells]. Yu Z; Fan QY; Ma BA; Hao XB; Long H Ai Zheng; 2005 Mar; 24(3):285-91. PubMed ID: 15757528 [TBL] [Abstract][Full Text] [Related]
66. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors. Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988 [TBL] [Abstract][Full Text] [Related]
67. [The effect of tumor-dendritic cell fusion vaccines on the cytotoxicity of CIK/NK cells from cord blood]. Li Y; Huang SL; Wu YF; Wei J; Meng Y; Zhou DH; Bao R Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):269-72. PubMed ID: 15949286 [TBL] [Abstract][Full Text] [Related]
68. Tumor-dendritic cell fusion as a basis for cancer immunotherapy. Lee WT; Shimizu K; Kuriyama H; Tanaka H; Kjaergaard J; Shu S Otolaryngol Head Neck Surg; 2005 May; 132(5):755-64. PubMed ID: 15886631 [TBL] [Abstract][Full Text] [Related]
69. [Treatment of spontaneous metastatic lung cancer with interleukin-12 gene-modified dendritic cells vaccine]. Chen JQ; Xiu QY; Shen C; Yan ZM Ai Zheng; 2002 Dec; 21(12):1328-31. PubMed ID: 12520741 [TBL] [Abstract][Full Text] [Related]
70. Autoimmune response induced by dendritic cells exerts anti-tumor effect in murine model of leukemia. Tsai BY; Lin YL; Chiang BL J Autoimmun; 2010 Jun; 34(4):364-70. PubMed ID: 19818583 [TBL] [Abstract][Full Text] [Related]
71. Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma. Alshamsan A Immunopharmacol Immunotoxicol; 2012 Jun; 34(3):465-9. PubMed ID: 21999714 [TBL] [Abstract][Full Text] [Related]
72. [Anti-leukemia immunity induced by dendritic cells fused with L615 tumor cells]. Yu JP; Li M; Ge W; Ma S; You SG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):351-5. PubMed ID: 16638213 [TBL] [Abstract][Full Text] [Related]
74. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination. Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730 [TBL] [Abstract][Full Text] [Related]
75. Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion. Linardakis E; Bateman A; Phan V; Ahmed A; Gough M; Olivier K; Kennedy R; Errington F; Harrington KJ; Melcher A; Vile R Cancer Res; 2002 Oct; 62(19):5495-504. PubMed ID: 12359759 [TBL] [Abstract][Full Text] [Related]
77. Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells. Hegmans JP; Hemmes A; Aerts JG; Hoogsteden HC; Lambrecht BN Am J Respir Crit Care Med; 2005 May; 171(10):1168-77. PubMed ID: 15764728 [TBL] [Abstract][Full Text] [Related]
78. A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines. Phan V; Errington F; Cheong SC; Kottke T; Gough M; Altmann S; Brandenburger A; Emery S; Strome S; Bateman A; Bonnotte B; Melcher A; Vile R Nat Med; 2003 Sep; 9(9):1215-9. PubMed ID: 12925849 [TBL] [Abstract][Full Text] [Related]
79. Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo. Qiu J; Li GW; Sui YF; Song HP; Si SY; Ge W World J Gastroenterol; 2006 Jan; 12(3):473-8. PubMed ID: 16489653 [TBL] [Abstract][Full Text] [Related]
80. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma. Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]